|
|
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Application of Immune Checkpoint Inhibition in the Management of Metastatic Lung CancerNovember 8, 2018, Washington, DC Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Application of Immune Checkpoint Inhibition in the Management of Metastatic Lung Cancer |